Decreased Expression of a Novel lncRNA FAM181A-AS1 is Associated with Poor Prognosis and Immune Infiltration in Lung Adenocarcinoma.

Weiquan LiangYiyu LuXing-Xi PanYunxiang ZengWeiqiang ZhengYiran LiYuanhang NieDongbing LiDongliang Wang

Published in: Pharmacogenomics and personalized medicine (2022)

There was a significant association between low FAM181A-AS1 expression in LUAD patients and poor survival and immune infiltration. The FAM181A-AS1 gene may provide a useful biomarker for LUAD prognosis and immunotherapy response.

Keyphrases

poor prognosis
long non coding rna
end stage renal disease
newly diagnosed
ejection fraction
prognostic factors
peritoneal dialysis
genome wide
copy number
gene expression
free survival